MedPath

Clovimax

Brand Name: Clovimax

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-3730

Dosage Form

Powder For Suspension

Issuance Date

April 2, 2024

Expiry Date

July 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength457 mg per 5 mL
PackagingPlastic Bottle x 70 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform